Get the latest delivered to your inbox
Privacy Policy

Now Reading

CytoDyn Supports Team Hope in the 4th Annual Action Cycling 200

CytoDyn Supports Team Hope in the 4th Annual Action Cycling 200

Published 04-19-06

Submitted by CytoDyn

SANTA FE, N.M.--(BUSINESS WIRE)--April 19, 2006--CytoDyn, Inc. (OTCBB:CYDY) is the primary sponsor of Team Hope in this year's Action Cycling, a challenging, two-day, 200-mile bicycle ride that will take place the weekend of May 20-21, 2006, in Georgia. The goal of the event is to build public awareness for HIV/AIDS, raise funds to support HIV/AIDS vaccine research, and provide services for people living with HIV/AIDS. This year's beneficiary is The Hope Clinic at the Emory Vaccine Center.

"I'm proud to be a part of Team Hope and excited about the level of support provided by CytoDyn this year," said team member Tom Godfrey. "Being associated with a fundraising event for a world-class clinical research facility like The Hope Clinic, along with the support of CytoDyn for our fundraising team, has helped me feel like I'm making a difference for my friends in the global community living and dealing with HIV/AIDS," Godfrey continued.

The 4th Annual Action Cycling 200 is open to the general public. Registration will take place Friday, May 19, 2006, at the Emory Vaccine Center located at 954 Gatewood Rd., Atlanta, GA 30329. New members interested in joining Team Hope or supporting this fundraising event are welcome. Additional information is available from the Vaccine Center at Emory University www.vaccines.emory.edy.

CytoDyn is developing the first targeted immune therapy for HIV/AIDS that has been shown to decrease viral burden in preliminary clinical trials. For more information, visit www.cytodyn.com.

Forward looking statements are statements that are not historical facts. CytoDyn's management makes forward looking statements concerning the Company's expected future operations, performance and other developments. These forward-looking statements are necessarily estimates based upon current information and involve a number of risks and uncertainties. There can be no assurance that such risks and uncertainties, or other factors, will not affect the accuracy of such forward-looking statements. It is impossible to identify all factors that could cause actual results to differ materially from those estimated by the Company. They include, but are not limited to, government regulation, managing and maintaining growth, victimization by white-collar offenders, and the effects of adverse publicity, litigation, competition, and other factors that may be identified from time to time in the Company's announcements.

Copyright Business Wire 2006

CytoDyn

CytoDyn

More from CytoDyn

Join today and get the latest delivered to your inbox